-
Das, A, Sudhaman, S, Morgenstern, D, Coblentz, A, Chung, J, Stone, SC, Alsafwani, N, Liu, ZA, Karsaneh, OAA, Soleimani, S, et al.
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency..
Nat Med
28(1)
:
125 -135
2022
view publication
-
Hansford, JR, Huang, J, Endersby, R, Dodgshun, AJ, Li, BK, Hwang, E, Leary, S, Gajjar, A, Von Hoff, K, Wells, O, et al.
Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic data..
Neurooncol Adv
4(1)
:
vdac056
2022
view publication
-
Lee, J, Gillam, L, Kouw, S, McCarthy, MC, Hansford, JR.
An institutional audit of the use of novel drugs in pediatric oncology..
Cancer Rep (Hoboken)
4(6)
:
e1404
2021
view publication
-
Khan, S, Solano-Paez, P, Hansford, JR, Lu, M, Al-karmi, S, Leung, L, Plant-Fox, A, La Spina, M, Andrew, E, Dunham, C, et al.
INNV-43. MORE THAN WHAT MEETS THE EYE: ETMR AN UNDER RECOGNISED ATYPICAL BRAINSTEM PRIMARY. A RARE BRAIN TUMOR CONSORTIUM (RBTC) STUDY.
Neuro-Oncology
23(Supplement_6)
:
vi114 -vi115
2021
view publication
-
Doz, F, van Tilburg, CM, Geoerger, B, Nysom, K, Øra, I, Boni, V, Chisholm, J, Chung, HC, DuBois, SG, Melcón, SG, et al.
CTNI-58. EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT AND PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS.
Neuro-Oncology
23(Supplement_6)
:
vi73 -vi74
2021
view publication